International Journal of Clinical Research & Trials Volume 1 (2016), Article ID 1:IJCRT-105, 1 pages
https://doi.org/10.15344/2456-8007/2016/105
https://doi.org/10.15344/2456-8007/2016/105
Commentary
Clinical Trials under the New European Regulation: An Update
References
- European Commission. Proposal for a Regulation of the European Parliament and of the Council on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC, July 17, 2012 COM(2012)369 final, p. 2-3
- Officially, EU Regulation 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC
- Kenter MJH, Cohen AF (2012) Re-engineering the European Union Clinical Trials Directive. The Lancet 379: 1765-1767 [CrossRef] [Google Scholar] [PubMed]
- Commission Staff Working Document. Impact assessment report on the revision of the “Clinical Trials Directive” 2001/20/EC, Brussels 17.7.2012 SWD(2012)200 final, vol. I, p. 21-23
- Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, et al. (2009) Ethical and Scientific Implications of the Globalization of Clinical Research. N ENGL J Med 36: 816-823 [CrossRef] [Google Scholar] [PubMed]
- Heringaand Dute, ‘The proposed EU-regulation on Clinical Trials on Medicinal Products: An Unethical Proposal?’ (2013) 4 EJHL 347-362; at 349